NDC 0904-7064
Atovaquone
Atovaquone
Atovaquone is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Atovaquone.
| Product ID | 0904-7064_31ad4347-790f-479f-a737-96a667380289 |
| NDC | 0904-7064 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Atovaquone |
| Generic Name | Atovaquone |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-10-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210692 |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | ATOVAQUONE |
| Active Ingredient Strength | 750 mg/5mL |
| Pharm Classes | Antimalarial [EPC],Antiprotozoal [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |